NeXstar Pharmaceuticals signs aptamer deal with Roche
This article was originally published in Clinica
Executive Summary
NeXstar Pharmaceuticals is developing synthetic oligonucleotides to replace heat sensitive components in Roche's PCR test kits. Under the terms of a collaboration between the two companies NeXstar will supply Roche with synthetic oligonucleotides, or aptamers, that increase the sensitivity of PCR amplification of DNA.